First-Line Treatment with Brief-Duration Chemotherapy Plus Rituximab in Elderly Patients with Intermediate-Grade Non-Hodgkin's Lymphoma: Phase II Trial-Reference-Cited by-同舟云学术

First-Line Treatment with Brief-Duration Chemotherapy Plus Rituximab in Elderly Patients with Intermediate-Grade Non-Hodgkin's Lymphoma: Phase II Trial

Published:2003-06 Issue:1 Volume:4 Page:36-42
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Hainsworth John D.,Litchy Sharlene,Lamb M. Ray,Rodriguez Gladys I.,Scroggin Jr. Carroll,Greco F. Anthony

Publisher

Elsevier BV

Subject

Cancer Research

Reference22 articles.

1. A predictive model for aggressive non-Hodgkin's lymphoma;The International Non-Hodgkin's Lymphoma Prognostic Factors Project;N Engl J Med,1993

2. Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate or high-grade histology;Bessel;Eur J Cancer,1994

3. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma;Vose;J Clin Oncol,1988

4. Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma;Solal-Celigny;Am J Med,1987

5. Full-dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen;Sonneveld;Br J Cancer,1990

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy Induced Cardiotoxicity: A State of the Art Review on General Mechanisms, Prevention, Treatment and Recent Advances in Novel Therapeutics;Current Problems in Cardiology;2023-04

2. Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2019-03

3. Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era;Leukemia & Lymphoma;2018-04-04

4. Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation;International Journal of Hematology;2016-10-27

5. Rituximab (Rituxan®);Handbook of Therapeutic Antibodies;2014-08-12